FOXD2-AS1 Promotes Malignant Cell Behavior in Oral Squamous Cell Carcinoma Via the MiR-378 g/CRABP2 Axis

Overview

Journal BMC Oral Health

Publisher Biomed Central

Specialty Dentistry

Date 2024 May 28

PMID 38807101

Authors

Shaoyong Guo

Bixia Huang

Zhisong You

Zhenzhi Luo

Da Xu

Jieru Zhang

Jialin Lin

Affiliations

Soon will be listed here.

Abstract

Background: Oral squamous cell cancer (OSCC) is a prevalent malignancy in oral cavity, accounting for nearly 90% of oral malignancies. It ranks sixth among the most common types of cancer worldwide and is responsible for approximately 145,000 deaths each year. It is widely accepted that noncoding RNAs participate cancer development in competitive regulatory interaction, knowing as competing endogenous RNA (ceRNA) network, whereby long non-coding RNA (lncRNA) function as decoys of microRNAs to regulate gene expression. LncRNA FOXD2-AS1 was reported to exert an oncogenic role in OSCC. Nevertheless, the ceRNA network mediated by FOXD2-AS1 was not investigated yet. This study aimed to explore the effect of FOXD2-AS1 on OSCC cell process and the underlying ceRNA mechanism.

Methods: FOXD2-AS1 expression in OSCC cells were determined via reverse transcription and quantitative polymerase chain reaction. Short hairpin RNA targeting FOXD2-AS1 was transfected into OSCC cells to silence FOXD2-AS1 expression. Then, loss-of-function experiments (n = 3 each assay) were performed to measure cell proliferation, apoptosis, migration, and invasion using colony formation, TdT-mediated dUTP Nick-End Labeling, wound healing and Transwell assays, respectively. RNA binding relation was verified by RNA immunoprecipitation and luciferase reporter assays. Rescue experiments were designed to validate whether FOXD2-AS1 affects cell behavior via the gene cellular retinoic acid binding protein 2 (CRABP2). Statistics were processed by GraphPad Prism 6.0 Software and SPSS software.

Results: FOXD2-AS1 was significantly upregulated in Cal27 and SCC9 cells (6.8 and 6.4 folds). In response to FOXD2-AS1 knockout, OSCC cell proliferation, migration and invasion were suppressed (approximately 50% decrease) while OSCC cell apoptosis was enhanced (more than two-fold increase). FOXD2-AS1 interacted with miR-378 g to alter CRABP2 expression. CRABP2 upregulation partly rescued (*p < 0.05, **p < 0.01, ***p < 0.001) the inhibitory impact of FOXD2-AS1 depletion on malignant characteristics of OSCC cells.

Conclusion: FOXD2-AS1 enhances OSCC malignant cell behaviors by interacting with miR-378 g to regulate CRABP2 expression.

Citing Articles

Non-coding RNAs in oral cancer: Emerging biomarkers and therapeutic frontier.

Hashemi M, Khoushab S, Hobabi Aghmiuni M, Anaraki S, Alimohammadi M, Taheriazam A Heliyon. 2024; 10(21):e40096.

PMID: 39583806 PMC: 11582460. DOI: 10.1016/j.heliyon.2024.e40096.

References

Xie T, Tan M, Gao Y, Yang H . CRABP2 accelerates epithelial mesenchymal transition in serous ovarian cancer cells by promoting TRIM16 methylation via upregulating EZH2 expression. Environ Toxicol. 2022; 37(8):1957-1967. DOI: 10.1002/tox.23542. View

Fu X, Zhang Q, Wang Z, Xu Y, Dong Q . CRABP2 affects chemotherapy resistance of ovarian cancer by regulating the expression of HIF1α. Cell Death Dis. 2024; 15(1):21. PMC: 10776574. DOI: 10.1038/s41419-023-06398-4. View

Tang J, Fang X, Chen J, Zhang H, Tang Z . Long Non-Coding RNA (lncRNA) in Oral Squamous Cell Carcinoma: Biological Function and Clinical Application. Cancers (Basel). 2021; 13(23). PMC: 8656574. DOI: 10.3390/cancers13235944. View

Lin T, Zhou F, Zhou H, Pan X, Sun Z, Peng G . MicroRNA-378g enhanced radiosensitivity of NPC cells partially by targeting protein tyrosine phosphatase SHP-1. Int J Radiat Biol. 2015; 91(11):859-66. DOI: 10.3109/09553002.2015.1096028. View

Li W, Zhu Q, Zhang S, Liu L, Zhang H, Zhu D . HOXC13-AS accelerates cell proliferation and migration in oral squamous cell carcinoma via miR-378g/HOXC13 axis. Oral Oncol. 2020; 111:104946. DOI: 10.1016/j.oraloncology.2020.104946. View

Deng L, Yang S, Xu F, Zhang J . Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge. J Exp Clin Cancer Res. 2015; 34:18. PMC: 4339002. DOI: 10.1186/s13046-015-0136-7. View

Gungormez C, Aktas H, Dilsiz N, Borazan E . Novel miRNAs as potential biomarkers in stage II colon cancer: microarray analysis. Mol Biol Rep. 2019; 46(4):4175-4183. DOI: 10.1007/s11033-019-04868-7. View

Yan X, Hu Z, Feng Y, Hu X, Yuan J, Zhao S . Comprehensive Genomic Characterization of Long Non-coding RNAs across Human Cancers. Cancer Cell. 2015; 28(4):529-540. PMC: 4777353. DOI: 10.1016/j.ccell.2015.09.006. View

Li H, Zhang Y, Xu M, Yang D . Current trends of targeted therapy for oral squamous cell carcinoma. J Cancer Res Clin Oncol. 2022; 148(9):2169-2186. DOI: 10.1007/s00432-022-04028-8. View

10.

Cui P, Dai X, Liu R, Cao H . LncRNA LINC00888 upregulation predicts a worse survival of laryngeal cancer patients and accelerates the growth and mobility of laryngeal cancer cells through regulation of miR-378g/TFRC. J Biochem Mol Toxicol. 2021; 35(10):e22878. DOI: 10.1002/jbt.22878. View

11.

Zhu X, Yuan J, Zhu T, Li Y, Cheng X . Long noncoding RNA glypican 3 (GPC3) antisense transcript 1 promotes hepatocellular carcinoma progression via epigenetically activating GPC3. FEBS J. 2016; 283(20):3739-3754. DOI: 10.1111/febs.13839. View

12.

Rong L, Zhao R, Lu J . Highly expressed long non-coding RNA FOXD2-AS1 promotes non-small cell lung cancer progression via Wnt/β-catenin signaling. Biochem Biophys Res Commun. 2017; 484(3):586-591. DOI: 10.1016/j.bbrc.2017.01.141. View

13.

Liu Z, Zhou W, Lin C, Wang X, Zhang X, Zhang Y . Dysregulation of FOXD2-AS1 promotes cell proliferation and migration and predicts poor prognosis in oral squamous cell carcinoma: a study based on TCGA data. Aging (Albany NY). 2020; 13(2):2379-2396. PMC: 7880351. DOI: 10.18632/aging.202268. View

14.

Aldelaimi T, Khalil A . Reconstruction of Facial Defect Using Deltopectoral Flap. J Craniofac Surg. 2015; 26(8):e786-8. DOI: 10.1097/SCS.0000000000002056. View

15.

Liu C, Hsu Y, Kuo C, Jhuang J, Li Y, Cheng S . CRABP2 Is Associated With Thyroid Cancer Recurrence and Promotes Invasion via the Integrin/FAK/AKT Pathway. Endocrinology. 2022; 163(12). DOI: 10.1210/endocr/bqac171. View

16.

Calmon M, Rodrigues R, Kaneto C, Moura R, Silva S, Mota L . Epigenetic silencing of CRABP2 and MX1 in head and neck tumors. Neoplasia. 2009; 11(12):1329-39. PMC: 2794514. DOI: 10.1593/neo.91110. View

17.

Mody M, Rocco J, Yom S, Haddad R, Saba N . Head and neck cancer. Lancet. 2021; 398(10318):2289-2299. DOI: 10.1016/S0140-6736(21)01550-6. View

18.

David F, Rougemont J, Deplancke B . GETPrime 2.0: gene- and transcript-specific qPCR primers for 13 species including polymorphisms. Nucleic Acids Res. 2017; 45(D1):D56-D60. PMC: 5210624. DOI: 10.1093/nar/gkw913. View

19.

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

20.

Fan T, Wang X, Zhang S, Deng P, Jiang Y, Liang Y . NUPR1 promotes the proliferation and metastasis of oral squamous cell carcinoma cells by activating TFE3-dependent autophagy. Signal Transduct Target Ther. 2022; 7(1):130. PMC: 9035452. DOI: 10.1038/s41392-022-00939-7. View